Abstract
Gut microbiota (GM) dysbiosis is closely related to several metabolic diseases such as hypertension, obesity, and Alzheimer’s disease. However, little is known about the causal relationship between GM dysbiosis and osteoporosis. In our work, 32 3-month-old female SD rats were randomly divided into two groups: the fecal microbiota transplantation (FMT) group and the control group. The supernatant of feces from senile osteoporotic rats was transplanted to the FMT group and the same amount of sterile saline was given to the control rats. After 12 and 24 weeks, all rats were sacrificed, and the serum, bone, fecal feces, and intestine tissue were collected for the subsequent analysis. The osteocalcin (OC), CTX, and P1NP of the FMT group increased significantly at 12 and 24 weeks compared with the control group (P < 0.05). Furthermore, the BV, BV/TV, Tb.N, and Tb.Th decreased significantly in the FMT group (P < 0.05). The alpha diversity (ACE, Chao) of the FMT group was higher than the control at 24 weeks (P < 0.05). The beta diversity was close between the FMT rats and the donor rats. In addition, GM from donor rats changed the GM composition and function of the FMT rats, which was similar to that of the donor rats at 24 weeks. The impaired intestinal structure and the decreased expression of occludin, claudin, and ZO-1 were found in FMT rats. In conclusion, GM dysbiosis by transferring the feces from senile osteoporotic rats to young rats could induce osteoporosis. The changed GM and the impaired intestinal barrier contributed to the pathogenesis of osteoporosis.
Similar content being viewed by others
References
Ensrud KE, Crandall CJ (2017) Osteoporosis. Ann Intern Med 167:ITC17–ITC32. https://doi.org/10.7326/AITC201708010
Brown C (2017) Osteoporosis: staying strong. Nature 550:S15–S17. https://doi.org/10.1038/550S15a
Riggs BL, Melton LJ (1983) Evidence for two distinct syndromes of involutional osteoporosis. Am J Med 75:899–901. https://doi.org/10.1016/0002-9343(83)90860-4
Voreades N, Kozil A, Weir TL (2014) Diet and the development of the human intestinal microbiome. Front Microbiol 5:494. https://doi.org/10.3389/fmicb.2014.00494
Abenavoli L, Scarpellini E, Colica C et al (2019) Gut microbiota and obesity: a role for probiotics. Nutrients. https://doi.org/10.3390/nu11112690
Benakis C, Brea D, Caballero S et al (2016) Commensal microbiota affects ischemic stroke outcome by regulating intestinal γδ T cells. Nat Med 22:516–523. https://doi.org/10.1038/nm.4068
Gurung M, Li Z, You H et al (2020) Role of gut microbiota in type 2 diabetes pathophysiology. EBioMedicine 51:102590. https://doi.org/10.1016/j.ebiom.2019.11.051
Liu F, Fan C, Zhang L et al (2020) Alterations of gut microbiome in Tibetan patients with coronary heart disease. Front Cell Infect Microbiol 10:373. https://doi.org/10.3389/fcimb.2020.00373
Sjögren K, Engdahl C, Henning P et al (2012) The gut microbiota regulates bone mass in mice. J Bone Miner Res 27:1357–1367. https://doi.org/10.1002/jbmr.1588
Yan J, Herzog JW, Tsang K et al (2016) Gut microbiota induce IGF-1 and promote bone formation and growth. Proc Natl Acad Sci USA 113:E7554–E7563. https://doi.org/10.1073/pnas.1607235113
Schwarzer M, Makki K, Storelli G et al (2016) Lactobacillus plantarum strain maintains growth of infant mice during chronic undernutrition. Science 351:854–857. https://doi.org/10.1126/science.aad8588
Ma S, Qin J, Hao Y et al (2020) Structural and functional changes of gut microbiota in ovariectomized rats and their correlations with altered bone mass. Aging (Albany NY). https://doi.org/10.18632/aging.103290
Ma S, Qin J, Hao Y, Fu L (2020) Association of gut microbiota composition and function with an aged rat model of senile osteoporosis using 16S rRNA and metagenomic sequencing analysis. Aging (Albany NY). https://doi.org/10.18632/aging.103293
Wang J, Wang Y, Gao W et al (2017) Diversity analysis of gut microbiota in osteoporosis and osteopenia patients. PeerJ 5:e3450. https://doi.org/10.7717/peerj.3450
Li C, Huang Q, Yang R et al (2019) Gut microbiota composition and bone mineral loss-epidemiologic evidence from individuals in Wuhan, China. Osteoporos Int 30:1003–1013. https://doi.org/10.1007/s00198-019-04855-5
Das M, Cronin O, Keohane DM et al (2019) Gut microbiota alterations associated with reduced bone mineral density in older adults. Rheumatology (Oxford) 58:2295–2304. https://doi.org/10.1093/rheumatology/kez302
Xu Z, Xie Z, Sun J et al (2020) Gut microbiome reveals specific dysbiosis in primary osteoporosis. Front Cell Infect Microbiol 10:160. https://doi.org/10.3389/fcimb.2020.00160
He J, Xu S, Zhang B et al (2020) Gut microbiota and metabolite alterations associated with reduced bone mineral density or bone metabolic indexes in postmenopausal osteoporosis. Aging (Albany NY). https://doi.org/10.18632/aging.103168
Chen C, Ahn EH, Kang SS et al (2020) Gut dysbiosis contributes to amyloid pathology, associated with C/EBPβ/AEP signaling activation in Alzheimer’s disease mouse model. Sci Adv 6:eaba0466. https://doi.org/10.1126/sciadv.aba0466
Ma C, Sun Z, Zeng B et al (2018) Cow-to-mouse fecal transplantations suggest intestinal microbiome as one cause of mastitis. Microbiome 6:200. https://doi.org/10.1186/s40168-018-0578-1
Li J, Zhao F, Wang Y et al (2017) Gut microbiota dysbiosis contributes to the development of hypertension. Microbiome 5:14. https://doi.org/10.1186/s40168-016-0222-x
Gomes AC, Hoffmann C, Mota JF (2018) The human gut microbiota: metabolism and perspective in obesity. Gut Microbes 9:308–325. https://doi.org/10.1080/19490976.2018.1465157
Chang C-J, Lin C-S, Lu C-C et al (2015) Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota. Nat Commun 6:7489. https://doi.org/10.1038/ncomms8489
Fu L, Wu W, Sun X, Zhang P (2020) Glucocorticoids enhanced osteoclast autophagy through the PI3K/Akt/mTOR signaling pathway. Calcif Tissue Int 107:60–71. https://doi.org/10.1007/s00223-020-00687-2
Quast C, Pruesse E, Yilmaz P et al (2013) The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res 41:D590-596. https://doi.org/10.1093/nar/gks1219
Li L, Li X, Zhong W et al (2019) Gut microbiota from colorectal cancer patients enhances the progression of intestinal adenoma in Apcmin/+ mice. EBioMedicine 48:301–315. https://doi.org/10.1016/j.ebiom.2019.09.021
Zhu Y, He C, Li X et al (2019) Gut microbiota dysbiosis worsens the severity of acute pancreatitis in patients and mice. J Gastroenterol 54:347–358. https://doi.org/10.1007/s00535-018-1529-0
Kelly JR, Borre Y, O’Brien C et al (2016) Transferring the blues: depression-associated gut microbiota induces neurobehavioural changes in the rat. J Psychiatr Res 82:109–118. https://doi.org/10.1016/j.jpsychires.2016.07.019
Matsuoka K, Kanai T (2015) The gut microbiota and inflammatory bowel disease. Semin Immunopathol 37:47–55. https://doi.org/10.1007/s00281-014-0454-4
Bostanciklioğlu M (2019) The role of gut microbiota in pathogenesis of Alzheimer’s disease. J Appl Microbiol 127:954–967. https://doi.org/10.1111/jam.14264
Wen L, Duffy A (2017) Factors influencing the gut microbiota, inflammation, and type 2 diabetes. J Nutr 147:1468S-1475S. https://doi.org/10.3945/jn.116.240754
Shen F, Zheng R-D, Sun X-Q et al (2017) Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease. Hepatobiliary Pancreat Dis Int 16:375–381. https://doi.org/10.1016/S1499-3872(17)60019-5
Zou R, Xu F, Wang Y et al (2020) Changes in the gut microbiota of children with autism spectrum disorder. Autism Res 13:1614–1625. https://doi.org/10.1002/aur.2358
Huang H, Ren Z, Gao X et al (2020) Integrated analysis of microbiome and host transcriptome reveals correlations between gut microbiota and clinical outcomes in HBV-related hepatocellular carcinoma. Genom Med 12:102. https://doi.org/10.1186/s13073-020-00796-5
Liu S, An Y, Cao B et al (2020) The composition of gut microbiota in patients bearing Hashimoto’s thyroiditis with euthyroidism and hypothyroidism. Int J Endocrinol 2020:5036959. https://doi.org/10.1155/2020/5036959
Atarashi K, Tanoue T, Shima T et al (2011) Induction of colonic regulatory T cells by indigenous Clostridium species. Science 331:337–341. https://doi.org/10.1126/science.1198469
Van den Abbeele P, Belzer C, Goossens M et al (2013) Butyrate-producing Clostridium cluster XIVa species specifically colonize mucins in an in vitro gut model. ISME J 7:949–961. https://doi.org/10.1038/ismej.2012.158
Loo Y-M, Gale M (2011) Immune signaling by RIG-I-like receptors. Immunity 34:680–692. https://doi.org/10.1016/j.immuni.2011.05.003
Grigorian A, Lee S-U, Tian W et al (2007) Control of T cell-mediated autoimmunity by metabolite flux to N-glycan biosynthesis. J Biol Chem 282:20027–20035. https://doi.org/10.1074/jbc.M701890200
Sugita K, Kabashima K (2020) Tight junctions in the development of asthma, chronic rhinosinusitis, atopic dermatitis, eosinophilic esophagitis, and inflammatory bowel diseases. J Leukoc Biol 107:749–762. https://doi.org/10.1002/JLB.5MR0120-230R
Li J-Y, Chassaing B, Tyagi AM et al (2016) Sex steroid deficiency-associated bone loss is microbiota dependent and prevented by probiotics. J Clin Invest 126:2049–2063. https://doi.org/10.1172/JCI86062
Schepper JD, Collins F, Rios-Arce ND et al (2020) Involvement of the gut microbiota and barrier function in glucocorticoid-induced osteoporosis. J Bone Miner Res. https://doi.org/10.1002/jbmr.3947
Acknowledgements
This study was supported by National Natural Science Foundation of China (Grant No. 82172456), the Cross-disciplinary Fund Projects of the Ninth People’s Hospital (Grant No. JYJC201809), Seeds Fund of Engineering Research Center of Digital Medicine of the Ministry of Education (Grant No. 20210407), Shanghai Clinical Medical Center (Grant No. 2017ZZ01023) and Shanghai Municipal Key Clinical Specialty.
Author information
Authors and Affiliations
Contributions
LF designed the experiments and supervised the project. SM performed the experiments and acquired the data. SM and NW analyzed the data. NW wrote the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
Ning Wang, Sicong Ma, and Lingjie Fu declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
The use of animals in this study was approved by the Animal Care and Use Committee of Shanghai Ninth People’s Hospital. All applicable institutional and/or national guidelines for the care and use of animals were followed.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Wang, N., Ma, S. & Fu, L. Gut Microbiota Dysbiosis as One Cause of Osteoporosis by Impairing Intestinal Barrier Function. Calcif Tissue Int 110, 225–235 (2022). https://doi.org/10.1007/s00223-021-00911-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00223-021-00911-7